Numbers in millions USD, except per-share numbers. Zynerba (NASDAQ: ZYNE) is dedicated to improving the lives of people with rare and near rare neuropsychiatric disorders where there is a high unmet medical need by pioneering the development and commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for transdermal delivery. ZYNE medical pharmaceuticals See Zynerba Pharmaceuticals, Inc. (ZYNE) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Find out more about how we use your information in our Privacy Policy and Cookie Policy. *Average 12-month price target from 6 stock analysts.

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. For subscribers only. All market data (will open in new tab) is provided by Barchart Solutions. Zynerba Pharmaceuticals Receives Orphan Drug Designation for Cannabidiol for the Treatment of 22q11.2 Deletion Syndrome, Zynerba Pharmaceuticals Provides Update on Recent Milestones, Zynerba Pharmaceuticals to Present at Two Upcoming Virtual Investor Conferences. Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. Realtime quote and/or trade prices are not sourced from all markets. Snack maker Amplify and solar company Sunrun fall after IPOs; drug developer Zynerba rises, Initial public offerings scheduled to debut next week, - GlobeNewswire - Thu Sep 17, 12:55PM CDT. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice.

Yahoo is part of Verizon Media. To view this site properly, enable cookies in your browser. According to Zacks Investment Research, "Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings. Information about your device and internet connection, including your IP address, Browsing and search activity while using Verizon Media websites and apps. Stats based on trailing-twelve-month (ttm) numbers. A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. We and our partners will store and/or access information on your device through the use of cookies and similar technologies, to display personalised ads and content, for ad and content measurement, audience insights and product development. Get detailed information on Zynerba Pharmaceuticals stock (NASDAQ: ZYNE), including today’s stock quote, real-time price, financial history, charts, and more. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. Here are some recent quotes from research analysts about Zynerba Pharmaceuticals stock: 1. 22q is a rare midline condition featuring physical abnormalities and debilitating neuropsychiatric and behavioral symptoms including anxiety, withdrawn behavior, and social interaction problems. How Has Zynerba Stock Performed in 2017/2018? "remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }, Unchecking box will stop auto data updates.